Impact of time from symptom onset to diagnosis in infective endocarditis: insights from the nationwide NIDUS registry - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Effects of Delay from Symptom Onset to Diagnosis in Infective Endocarditis: Findings from the National NIDUS Registry

  • By

  • Mads-Gustav Nebel Hvidt

  • Amna Alhakak

  • Peter Laursen Graversen

  • Katra Hadji-Turdeghal

  • Jacob Eifer Møller

  • Niels Eske Bruun

  • Kasper Karmark Iversen

  • Jonas Agerlund Povlsen

  • Claus Moser

  • Morten Holdgaard Smerup

  • Daniel Faurholt-Jepsen

  • Henning Bundgaard

  • Lauge Østergaard

  • Lars Køber

  • Emil Loldrup Fosbøl

  • August 31, 2026

Share

Clinical Report: Effects of Delay from Symptom Onset to Diagnosis in Infective Endocarditis

Overview

This study investigates the impact of the interval between symptom onset and diagnosis on clinical outcomes in infective endocarditis (IE) using data from the National NIDUS Registry.

Background

Infective endocarditis (IE) is a severe condition with non-specific symptoms that can lead to diagnostic challenges. Understanding the relationship between symptom duration and diagnosis is crucial.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The study utilized the National Danish Endocarditis Study (NIDUS) database, covering all patients diagnosed with IE in Denmark from 2016 to 2021.
  • Patients were categorized based on the interval between symptom onset and diagnosis: ≤7 days, 8–29 days, and ≥30 days.
  • Microbial aetiology was determined through blood cultures, with various pathogens identified including Staphylococcus aureus and Streptococcus spp.
  • Class I surgical indications were based on the 2015 ESC guidelines.

Clinical Implications

Healthcare professionals should be aware of the potential consequences of diagnostic delays in infective endocarditis. Timely diagnosis and treatment initiation may improve patient outcomes and reduce mortality associated with this condition.

Conclusion

The findings from the NIDUS Registry highlight the importance of understanding the impact of symptom duration on the diagnosis and management of infective endocarditis.

Related Resources & Content

  1. Open Forum Infectious Diseases, 2021 -- Timing of Antimicrobial Therapy in Infective Endocarditis: Is a Delay Justified?
  2. Open Forum Infectious Diseases, 2021 -- Assessment of Various Duke Criteria Versions for Diagnosing Infective Endocarditis in Patients with Enterococcal Bacteremia: A Multicenter Analysis
  3. Open Forum Infectious Diseases, 2021 -- Assessment of the 2023 Duke–International Society of Cardiovascular Infectious Diseases Guidelines in a Retrospective Multicenter Analysis of Patients With Intravenous Drug Use
  4. Open Forum Infectious Diseases, 2021 -- Evaluating Various Versions of Duke Criteria for Diagnosing Infective Endocarditis in Patients with Intracardiac Prosthetic Devices
  5. 2023 ESC Guidelines for the management of endocarditis | European Heart Journal | Oxford Academic
  6. Early Surgery versus Conventional Treatment for Infective Endocarditis | New England Journal of Medicine
  7. Impact of diagnostic and treatment delays on mortality in infective endocarditis: results from a large patient population study | European Heart Journal | Oxford Academic
  8. 2023 ESC Guidelines for the management of endocarditis | European Heart Journal | Oxford Academic
  9. Early Surgery versus Conventional Treatment for Infective Endocarditis | New England Journal of Medicine
  10. Impact of diagnostic and treatment delays on mortality in infective endocarditis: results from a large patient population study | European Heart Journal | Oxford Academic

Original Source(s)

Related Content